Artisan reports 9.5% stake in Twist Bioscience
Twist Bioscience Corporation disclosed that investment manager Artisan Partners and related entities filed an amended Schedule 13G reporting a sizable passive stake.
Rhea-AI Filing Summary
Twist Bioscience Corporation disclosed that investment manager Artisan Partners and related entities filed an amended Schedule 13G reporting a sizable passive stake. The group reports beneficial ownership of 5,830,205 shares of Twist common stock, or 9.5% of the class, based on 61,273,653 shares outstanding as of 12/26/2025.
Artisan entities report no sole voting or dispositive power. They share voting power over 4,959,392 shares and share dispositive power over 5,830,205 shares, held on behalf of discretionary clients of Artisan Partners Limited Partnership. The filing states the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Twist Bioscience.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Twist Bioscience (TWST) Schedule 13G/A filed by Artisan Partners report?
The Schedule 13G/A shows Artisan-related entities reporting a passive ownership stake in Twist Bioscience. They beneficially own 5,830,205 common shares, representing 9.5% of the company’s outstanding stock, held for discretionary clients of Artisan Partners Limited Partnership.
Is Artisan Partners’ ownership in Twist Bioscience (TWST) intended to influence control of the company?
The certification states the Twist Bioscience shares were acquired and are held in the ordinary course of business. It further states they were not acquired for the purpose of changing or influencing control of Twist Bioscience.
AI-generated analysis. How Rhea-AI works. Not financial advice.